Quanticoat 125 I-Theophylline Radioimmunoassay
by Kallestad Laboratories, Inc.
510(k) K821862
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK821862 | Date6 Jul 1982 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Quanticoat 125 I-Theophylline Radioimm.
- 510(k) Number
- FDA Product Code
- LCA
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3880
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Quanticoat 125 I-Theophylline Radioimmunoassay is a diagnostic in vitro device used for measuring theophylline levels in biological samples. Classified as a radioimmunoassay under the FDA’s regulation number 862.3880, it employs radiolabeled iodine-125 to quantify theophylline concentrations, aiding in clinical toxicology assessments.
This device is supplied as a single-use diagnostic kit and requires no sterilization beyond manufacturer-provided packaging. It is intended for use in laboratory settings, adhering to Class II regulatory standards under the FDA’s 510(k) clearance (K821862). Storage conditions and handling must comply with radioactive material regulations, and its use is governed by the product code LCA and advisory committee review for clinical toxicology applications.